Abstract

In situ neoplasm (or Carcinoma in situ (CIS)) is expression of malignant epithelial cells. This flat lesion is referred to as ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). Considering neoplasm leads one to an effectiveness survival analysis compared to the case that neoplasm is not attended. The objective of this research is to analyze statistically survival of invasive breast cancer patients considering 1) with in situ neoplasm, and 2) without in situ neoplasm, and providing a comparative analysis. This study attempts to reveal that the both medical history (such as diabetes, hypertension, and internal glands disorders such as hypo- and hyperthyroidism) and extra capsular extension play important roles in the hazard function of a patient’s survival analysis. This statistical study indicates that 1) the survival rate of breast cancer patients with in situ neoplasm is more than one who is not initially supported by invasive carcinoma, and 2) in the case of existence of the both in situ neoplasm and invasive malignancy, after the 4th year, the life expectancy is increased compared to the one with only invasive malignant. The statistical analysis indicates that pathology type is recognized as a high hazard factor for a breast cancer patient.

Highlights

  • Neoplasm can be categorized into two main branches: 1) invasive, and 2) non-invasive

  • The analysis of this research indicates that breast cancer patients with in situ neoplasms are placed in a higher survival rate compared to the patient type who refers to a therapeutic center initially with invasive carcinoma

  • The statistical analysis indicated that pathology type is recognized as a high hazard factor for breast cancer patients

Read more

Summary

Objectives

The objective of this research is to analyze statistically survival of invasive breast cancer patients considering 1) with in situ neoplasm, and 2) without in situ neoplasm, and providing a comparative analysis

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.